Your browser is no longer supported. Please, upgrade your browser.
Settings
GHDX Genomic Health, Inc. daily Stock Chart
GHDX [NASD]
Genomic Health, Inc.
Index- P/E148.26 EPS (ttm)0.50 Insider Own1.70% Shs Outstand36.12M Perf Week-7.82%
Market Cap2.65B Forward P/E63.82 EPS next Y1.15 Insider Trans-66.50% Shs Float35.10M Perf Month13.96%
Income18.60M PEG- EPS next Q0.29 Inst Own90.90% Short Float2.91% Perf Quarter29.32%
Sales377.00M P/S7.03 EPS this Y73.30% Inst Trans0.52% Short Ratio2.65 Perf Half Y91.37%
Book/sh6.85 P/B10.71 EPS next Y15.69% ROA7.10% Target Price61.71 Perf Year155.71%
Cash/sh5.07 P/C14.47 EPS next 5Y- ROE8.70% 52W Range26.54 - 92.18 Perf YTD114.59%
Dividend- P/FCF42.96 EPS past 5Y-19.50% ROI-4.20% 52W High-20.38% Beta0.38
Dividend %- Quick Ratio4.90 Sales past 5Y7.70% Gross Margin83.50% 52W Low176.53% ATR4.76
Employees863 Current Ratio4.90 Sales Q/Q20.90% Oper. Margin4.40% RSI (14)49.81 Volatility5.83% 6.39%
OptionableYes Debt/Eq0.00 EPS Q/Q608.80% Profit Margin4.90% Rel Volume1.33 Prev Close76.20
ShortableYes LT Debt/Eq0.00 EarningsNov 06 AMC Payout0.00% Avg Volume385.56K Price73.39
Recom3.00 SMA200.39% SMA505.91% SMA20048.16% Volume510,759 Change-3.69%
Oct-23-18Resumed Raymond James Mkt Perform
Jun-13-18Downgrade Ladenburg Thalmann Buy → Neutral
Dec-20-17Downgrade William Blair Outperform → Mkt Perform
Dec-13-17Downgrade JP Morgan Neutral → Underweight
May-03-17Downgrade Raymond James Outperform → Mkt Perform
Jan-18-17Initiated Deutsche Bank Hold $31
Feb-11-16Reiterated Canaccord Genuity Buy $44 → $38
Jan-11-16Downgrade Piper Jaffray Overweight → Neutral
Jan-07-16Reiterated Barclays Underweight $25 → $27
Jan-06-16Upgrade Canaccord Genuity Hold → Buy $26 → $44
Nov-23-15Upgrade UBS Neutral → Buy $29 → $38
Nov-04-15Upgrade Raymond James Mkt Perform → Outperform
Sep-02-15Initiated Barclays Underweight $25
Aug-28-15Upgrade Raymond James Underperform → Mkt Perform
Aug-05-15Reiterated Canaccord Genuity Hold $28 → $26
Mar-10-15Initiated UBS Neutral $34
Aug-11-14Reiterated Canaccord Genuity Hold $30 → $27
Aug-02-13Reiterated MLV & Co Hold $30 → $35
Feb-21-12Downgrade GARP Research Buy → Neutral
Feb-08-12Downgrade MLV & Co Buy → Hold $31.50 → $30
Nov-19-18 04:13PM  3 High-Growth Stocks That Are Just Getting Started Motley Fool
08:00AM  Genomic Health Announces Presentation of Two Large Studies at the 2018 San Antonio Breast Cancer Symposium, Reinforcing Real-world Value of the Oncotype DX Breast Recurrence Score® Test PR Newswire
Nov-16-18 04:54PM  This High-Growth Biotech Industry Is as Competitive as Ever Heading Into 2019 Motley Fool
Nov-14-18 08:56AM  Genomic Health Starts Sprinting Motley Fool
Nov-12-18 11:51AM  3 DNA Stocks That Are on the Uptrend InvestorPlace
Nov-09-18 10:20AM  Earnings Estimates Rising for Genomic Health (GHDX): Will It Gain? Zacks
08:21AM  Genomic Health (GHDX) Q3 Earnings and Revenues Top Estimates Zacks
Nov-08-18 08:10AM  The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering Benzinga -7.10%
08:00AM  Genomic Health to Present at the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum PR Newswire
Nov-07-18 12:48PM  Here's Why Genomic Health Popped as Much as 30.2% Today Motley Fool +27.39%
07:50AM  The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie Benzinga
07:09AM  Dow Jones Futures Jump On Election Results; 7 Big Movers On Earnings Investor's Business Daily
Nov-06-18 07:10PM  Genomic Health Inc (GHDX) Q3 2018 Earnings Conference Call Transcript Motley Fool
07:05PM  Genomic Health (GHDX) Surpasses Q3 Earnings and Revenue Estimates Zacks
05:59PM  Genomic Health: 3Q Earnings Snapshot Associated Press
05:04PM  This Highly Rated Medtech Just Crushed Quarterly Expectations Investor's Business Daily
04:05PM  Genomic Health Announces Record Revenue and Profit in Third Quarter 2018 Financial Results; Raises Full Year Guidance PR Newswire
Oct-30-18 04:19PM  IBD Stock Of The Day Aims For Third Quarter Of Double-Digit Growth Investor's Business Daily
08:00AM  Genomic Health to Announce Third Quarter 2018 Financial Results and Host Conference Call on Tuesday, November 6, 2018 PR Newswire
Oct-29-18 08:00AM  Medicare Establishes Final Local Coverage Determination (LCD) for Use of the Oncotype DX® AR-V7 Nucleus Detect Test in Patients with Metastatic Castrate Resistant Prostate Cancer Effective December 10 PR Newswire
Oct-22-18 08:00AM  Genomic Health Announces Multiple Studies Reinforcing Value of Oncotype DX® Tests in Guiding Treatment for Breast and Prostate Cancer Patients PR Newswire
Oct-18-18 08:15AM  New Research Coverage Highlights Altair Engineering, Genomic Health, Seres Therapeutics, REV Group, MACOM Technology Solutions, and New Mountain Finance Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Oct-16-18 10:54AM  Here's Why You Should Invest in GNC Holdings (GNC) Right Now Zacks +5.59%
Oct-11-18 02:02PM  How Did Genomic Health Incs (NASDAQ:GHDX) 1.9% ROE Fare Against The Industry? Simply Wall St.
09:50AM  Molecular Diagnostic Market Gains Momentum: 3 Stocks in Focus Zacks
07:27AM  Here's Why Genomic Health, Inc. Gained 14.8% in September Motley Fool
Oct-10-18 09:54AM  Genomic Health's Test Gets Favored by New NCCN Guidelines Zacks
Oct-09-18 04:15PM  New NCCN Breast Cancer Guidelines Elevate Oncotype DX Breast Recurrence Score® as the Only Preferred Multi-gene Test to Predict Chemotherapy Treatment PR Newswire
09:08AM  Here's Why You Should Invest in Genomic Health (GHDX) Now Zacks
Oct-04-18 10:24AM  Genomic Health's New Data on Oncotype DX GPS to Boost Uptake Zacks
Sep-28-18 08:00AM  New Published Data and Recent Positive Private Payor Coverage Decisions Underscore Value and Utility of the Oncotype DX Genomic Prostate Score® (GPS) Test PR Newswire
Sep-12-18 08:48AM  Genomic Health (GHDX) Hits a 52-Week High: What's Driving It? Zacks
08:00AM  Epic Sciences Announces Completion of $52 Million Series E Financing PR Newswire
05:00AM  [$$] Epic Sciences Gets $52 Million for Cancer Blood Tests The Wall Street Journal
Sep-07-18 08:00AM  German Health Technology Assessment Body (IQWiG) Concludes Only Oncotype DX® has Sufficient Evidence to Guide Breast Cancer Adjuvant Chemotherapy Decisions Based on Landmark TAILORx Study Results PR Newswire
Sep-06-18 08:44AM  Genomic Health Prostate Cancer Business Solid, Cost Woes Stay Zacks
01:02AM  Biocartis Group NV: BIOCARTIS ANNOUNCES H1 2018 RESULTS GlobeNewswire
Aug-29-18 09:59AM  Here's Why You Should Invest in Genomic Health (GHDX) Now Zacks
Aug-24-18 08:25AM  Report: Exploring Fundamental Drivers Behind HomeStreet, Schnitzer Steel Industries, OraSure Technologies, Genomic Health, Benchmark Electronics, and Stoneridge New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Aug-13-18 01:39AM  Edited Transcript of GHDX earnings conference call or presentation 2-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-08-18 04:23PM  Genomic Health Starts Its Marathon Motley Fool
Aug-03-18 10:16AM  Genomic Health (GHDX) Q2 Earnings and Revenues Top Estimates Zacks
07:52AM  The Daily Biotech Pulse: Zafgen Executive Departs; Adamas, Acceleron Accelerate On Earnings Benzinga
Aug-02-18 07:50PM  Genomic Health (GHDX) Tops Q2 Earnings and Revenue Estimates Zacks
06:43PM  Genomic Health: 2Q Earnings Snapshot Associated Press
04:05PM  Genomic Health Announces Second Quarter 2018 Financial Results and Reports Recent Business Progress PR Newswire
02:30PM  Genomic Health, Inc. to Host Earnings Call ACCESSWIRE
08:54AM  The Daily Biotech Pulse: Denali's Parkinson's Candidate Clears Early-Stage Trials, Dexcom's Strong Quarter Benzinga
Jul-26-18 08:00AM  Genomic Health to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 2, 2018 PR Newswire
Jul-20-18 11:35AM  Lilly (LLY) Issues Update on Diabetes Drug Trulicity Label Zacks
10:05AM  Here's Why You Should Add Abbott (ABT) to Your Portfolio Now Zacks
09:28AM  Can the Rally in Genomic Health (GHDX) Shares Continue? Zacks
08:43AM  AVEO Pharmaceuticals (AVEO) Soars: Stock Adds 11.8% in Session Zacks
08:01AM  Intuitive Surgical (ISRG) Beats on Q2 Earnings & Revenues Zacks
Jul-19-18 11:17AM  Neogen (NEOG) Earnings and Revenues Beat Estimates in Q4 Zacks
09:24AM  Can Solid Global Prospects Drive Align's (ALGN) Q2 Earnings? Zacks
Jul-18-18 03:20PM  Abbott (ABT) Q2 Earnings & Revenues Top Estimates, View Up Zacks
Jul-17-18 09:50AM  Is Genomic Health (GHDX) Stock Outpacing Its Medical Peers This Year? Zacks
08:13AM  AngioDynamics (ANGO) Q4 Performance Dull, Competition Rife Zacks
06:56AM  Veeva Systems' Development Cloud Platform Picked by Idorsia Zacks
Jul-16-18 10:45AM  J&J's (JNJ) Invokana Label Expansion Filing Hit by FDA Delay Zacks
07:45AM  Here's Why You Should Invest in DaVIta (DVA) Stock Right Now Zacks
Jul-11-18 11:05AM  Achillion's 3rd Factor D Inhibitor Enters Clinical Studies Zacks
Jul-10-18 01:16PM  Top Stock Picks for the Week of July 9th Zacks
10:40AM  Abaxis (ABAX) and Zoetis Merger Deal Crosses HRS Hurdle Zacks
Jul-06-18 09:02AM  Arbutus Biopharma (ABUS) Jumps: Stock Rises 9.6% Zacks
Jul-05-18 10:42AM  Insulet Omnipod Insulin Pump Finds Favor in British Columbia Zacks
Jul-04-18 06:50AM  Here's Why You Should Invest in Masimo (MASI) Right Now Zacks
Jul-03-18 09:28AM  Integer Holdings Offloads AS&O, Focuses on Cardiac Units Zacks
09:27AM  Insulet Banks on Omnipod's Growing Market Reach, Runs Risks Zacks
08:14AM  Brush Off Volatility Concerns With These 5 Low-Beta Stocks Zacks
Jul-02-18 09:08AM  Here's Why You Should Hold Wright Medical (WMGI) Stock Now Zacks
Jun-29-18 11:24AM  Pfizer's Leukemia Candidate Gets Priority Review From FDA Zacks
09:05AM  Thermo Fisher to Buy Gatan, Boost Electron Microscopy Suite Zacks
07:46AM  MOHAP Selects Masimo's (MASI) Eve for CCHD Screening in UAE Zacks
Jun-28-18 11:29AM  Walgreens (WBA) Tops Q3 Earnings Estimates, Narrows View Zacks
11:00AM  Blood Test Predicts Treatment Response and Survival for Patients with Metastatic Prostate Cancer PR Newswire
10:40AM  Stryker (SYK) to Acquire SafeAir, Reduce Surgical Smoke Zacks
09:30AM  Here's Why You Should Steer Clear of Fresenius Medical Now Zacks
Jun-27-18 11:32AM  Agios Out-Licenses China Rights to Leukemia Drug Tibsovo Zacks -5.31%
11:08AM  Align Scripts New Success in EMEA, Lifts Global Progress Zacks
10:07AM  Patterson's (PDCO) NaVetor Launch to Boost Animal Health Unit Zacks
09:07AM  Integra LifeSciences Global Prospects Solid, Competition Rife Zacks
Jun-26-18 11:00AM  Pra Health Grows Organically, Symphony Synergies a Positive Zacks
10:45AM  Here's Why You Must Add STERIS (STE) to Your Portfolio Now Zacks
Jun-25-18 11:43AM  IDEXX Laboratories Global Growth Solid on Catalyst Uptake Zacks
08:36AM  Here's Why You Should Hold Merit Medical (MMSI) Stock Now Zacks
Jun-22-18 10:37AM  Why You Should Retain Quest Diagnostics in Your Portfolio Zacks
Jun-21-18 10:35AM  Paratek's Antibiotic Candidate Gets FDA Committee Date Zacks
08:49AM  Array BioPharma (ARRY) Looks Good: Stock Adds 5.2% in Session Zacks
Jun-20-18 10:08AM  Amgen Gets EU Nod to Add Survival Data on Blincyto's Label Zacks
08:44AM  REGENXBIO (RGNX) in Focus: Stock Moves 6.2% Higher Zacks
Jun-19-18 08:25AM  Research Report Identifies Synaptics, Ethan Allen Interiors, Urban Edge Properties, RPM International, Genomic Health, and United Community Banks with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jun-18-18 08:46AM  BioMarin Pharmaceutical (BMRN) Catches Eye: Stock Jumps 8.5% Zacks
08:23AM  ISRG or ITGR: Which is a Better Medical Instrument Stock? Zacks
Jun-15-18 08:50AM  Here's Why You Should Sell Patterson Companies Stock Now Zacks
08:30AM  Wright Medical Gets FDA PMA for AUGMENT Injectable, Shares Up Zacks
Jun-14-18 11:37AM  PetMed (PETS) Optimistic About New Orders Amid Cost Woes Zacks
11:33AM  Medtronic ActivaProgramming Application Wins FDA Nod for DBS Zacks
Jun-13-18 10:28AM  Idera Stock Down, Study on Dermatomyositis Candidate Fails Zacks
Genomic Health, Inc., a healthcare company, provides actionable genomic information to personalize cancer treatment decisions worldwide. It develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer, allowing physicians and patients to make individualized treatment decisions. The company offers the Oncotype DX invasive breast cancer test that is used for early stage invasive breast cancer patients to predict the breast cancer recurrence and chemotherapy benefit. It also provides the Oncotype DX colon cancer test, which is used to predict the likelihood of colon cancer recurrence in patients with stage II disease, as well as for use in patients with stage III disease treated with oxaliplatin-containing adjuvant therapy. In addition, the company provides the Oncotype DX tests for patients with ductal carcinoma in situ, a pre-invasive form of breast cancer; the Oncotype DX prostate cancer test, which provides a genomic prostate score to predict disease aggressiveness in men with low risk disease, as well as used to enhance treatment decisions for prostate cancer patients in conjunction with the Gleason score or tumor grading; and Oncotype DX AR-V7 Nucleus Detect test for men with metastatic castration-resistant prostate cancer. The company offers its products through a network of distributors. Genomic Health, Inc. has collaboration agreement with Epic Sciences, Inc.; license and development agreement with Biocartis N.V.; license agreement with Cleveland Diagnostics, Inc.; and a research collaboration agreement with Janssen Pharmaceuticals. The company was founded in 2000 and is based in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Popovits Kimberly JPresident and CEONov 16Option Exercise22.9815,000344,700191,982Nov 19 09:27 PM
Popovits Kimberly JPresident and CEONov 16Sale76.7215,0001,150,793176,982Nov 19 09:27 PM
Popovits Kimberly JPresident and CEONov 15Option Exercise22.9825,000574,500201,982Nov 19 09:27 PM
Popovits Kimberly JPresident and CEONov 15Sale77.1825,0001,929,560176,982Nov 19 09:27 PM
Cole G BradleyCFONov 13Option Exercise19.608,576168,07653,948Nov 15 04:04 PM
BAKER BROS. ADVISORS LPDirectorNov 13Sale79.69114,8589,153,05952,926Nov 13 06:35 PM
BAKER BROS. ADVISORS LPDirectorNov 13Sale78.50138,71210,889,35953,037Nov 13 06:33 PM
Cole G BradleyCFONov 13Sale79.188,576679,02745,372Nov 15 04:04 PM
BAKER BROS. ADVISORS LPDirectorNov 12Sale80.3814,4151,158,72453,233Nov 13 06:32 PM
BAKER BROS. ADVISORS LPDirectorNov 12Sale81.0765,5885,317,26553,170Nov 13 06:33 PM
Shak StevenChief Scientific OfficerNov 09Option Exercise17.335,50095,315342,241Nov 14 08:13 PM
BAKER BROS. ADVISORS LPDirectorNov 09Sale82.51169,34413,972,20153,247Nov 13 06:32 PM
BAKER BROS. ADVISORS LPDirectorNov 09Sale83.71107,7389,018,33753,408Nov 13 06:29 PM
Shak StevenChief Scientific OfficerNov 09Sale83.215,500457,646336,741Nov 14 08:13 PM
Cohen Fred EDirectorNov 08Option Exercise27.7510,000277,50077,464Nov 13 06:27 PM
Vaughn James JChief Commercial OfficerNov 08Option Exercise31.123,00093,36020,542Nov 13 06:29 PM
Vaughn James JChief Commercial OfficerNov 08Sale85.183,000255,54517,542Nov 13 06:29 PM
BAKER BROS. ADVISORS LPDirectorNov 08Sale86.5076,2736,597,50453,513Nov 13 06:26 PM
Cohen Fred EDirectorNov 08Sale87.9310,000879,26267,464Nov 13 06:27 PM
BAKER BROS. ADVISORS LPDirectorNov 08Sale85.5872,7456,225,15853,588Nov 13 06:22 PM
Pla FredericCOONov 07Option Exercise27.0843,5001,177,79679,038Nov 09 04:02 PM
Pla FredericCOONov 07Sale84.9143,5003,693,58935,538Nov 09 04:02 PM
Popovits Kimberly JPresident and CEOOct 16Option Exercise22.9825,000574,500201,982Oct 17 05:52 PM
Popovits Kimberly JPresident and CEOOct 16Sale66.2625,0001,656,524176,982Oct 17 05:52 PM
Popovits Kimberly JPresident and CEOOct 15Option Exercise22.9825,000574,500201,982Oct 17 05:52 PM
Popovits Kimberly JPresident and CEOOct 15Sale64.3125,0001,607,641176,982Oct 17 05:52 PM
Cole G BradleyCFOOct 10Option Exercise17.185,00085,90050,372Oct 11 07:58 PM
Cole G BradleyCFOOct 10Sale63.195,000315,95545,372Oct 11 07:58 PM
Vaughn James JChief Commercial OfficerOct 09Option Exercise27.5025,000687,56042,542Oct 10 06:02 PM
Shak StevenChief Scientific OfficerOct 09Option Exercise17.335,50095,315342,241Oct 11 07:59 PM
Shak StevenChief Scientific OfficerOct 09Sale64.355,500353,950336,741Oct 11 07:59 PM
Vaughn James JChief Commercial OfficerOct 09Sale64.3725,0001,609,32517,542Oct 10 06:02 PM
Vaughn James JChief Commercial OfficerOct 08Option Exercise30.4125,000760,15442,542Oct 10 06:02 PM
Pla FredericCOOOct 08Option Exercise27.001,50040,50037,038Oct 10 06:04 PM
Pla FredericCOOOct 08Sale65.431,50098,14835,538Oct 10 06:04 PM
Vaughn James JChief Commercial OfficerOct 08Sale65.3425,0001,633,51817,542Oct 10 06:02 PM
Cole G BradleyCOOSep 11Option Exercise17.185,00085,90050,372Sep 13 06:48 PM
Cole G BradleyCOOSep 11Sale64.015,000320,07445,372Sep 13 06:48 PM
Shak StevenChief Scientific OfficerSep 10Option Exercise27.335,500150,315342,241Sep 11 07:38 PM
Pla FredericChief Bus & Prod Dev OfficerSep 10Option Exercise27.001,50040,50037,038Sep 11 07:40 PM
Pla FredericChief Bus & Prod Dev OfficerSep 10Sale62.981,50094,46735,538Sep 11 07:40 PM
Shak StevenChief Scientific OfficerSep 10Sale63.055,500346,794336,741Sep 11 07:38 PM
Cohen Fred EDirectorSep 06Option Exercise34.448,250284,13075,572Sep 10 05:02 PM
Cohen Fred EDirectorSep 06Sale61.518,250507,45367,322Sep 10 05:02 PM
Popovits Kimberly JPresident and CEOAug 14Sale52.6060,0003,156,203176,982Aug 16 04:23 PM
Cole G BradleyCOOAug 09Option Exercise17.188,529146,52853,901Aug 10 06:41 PM
Pla FredericChief Bus & Prod Dev OfficerAug 09Option Exercise27.001,50040,50041,038Aug 10 06:45 PM
Shak StevenChief Scientific OfficerAug 09Option Exercise17.335,50095,315342,241Aug 10 06:47 PM
Shak StevenChief Scientific OfficerAug 09Sale55.925,500307,576336,741Aug 10 06:47 PM
Pla FredericChief Bus & Prod Dev OfficerAug 09Sale55.935,500307,62535,538Aug 10 06:45 PM
Cole G BradleyCOOAug 09Sale55.948,529477,10545,372Aug 10 06:41 PM
Radford Jason W.Chief Legal OfficerAug 08Sale56.394,126232,68134,050Aug 10 06:36 PM
Cohen Fred EDirectorAug 07Option Exercise25.798,250212,76875,572Aug 09 07:47 PM
Cohen Fred EDirectorAug 07Sale56.228,250463,80067,322Aug 09 07:47 PM
GRAHAM GINGER LDirectorAug 06Option Exercise17.3316,500285,94526,756Aug 08 04:28 PM
Popovits Kimberly JPresident and CEOJul 16Option Exercise17.1810,000171,800246,157Jul 18 04:40 PM
Popovits Kimberly JPresident and CEOJul 16Sale53.2710,000532,684236,157Jul 18 04:40 PM
Shak StevenChief Scientific OfficerJul 09Option Exercise17.335,50095,315341,416Jul 10 05:18 PM
Shak StevenChief Scientific OfficerJul 09Sale49.565,500272,554335,916Jul 10 05:18 PM
Popovits Kimberly JPresident and CEOJun 14Option Exercise17.1810,000171,800246,157Jun 18 07:16 PM
Popovits Kimberly JPresident and CEOJun 14Sale48.8910,000488,916236,157Jun 18 07:16 PM
Shak StevenChief Scientific OfficerJun 11Option Exercise17.335,50095,315341,416Jun 13 06:59 PM
Shak StevenChief Scientific OfficerJun 11Sale50.225,500276,200335,916Jun 13 06:59 PM
Vaughn James JChief Commercial OfficerJun 04Option Exercise25.9880,7682,097,99749,655Jun 06 07:57 PM
Vaughn James JChief Commercial OfficerJun 04Sale45.7893,4144,276,16517,009Jun 06 07:57 PM
Popovits Kimberly JPresident and CEOMay 14Option Exercise17.1810,000171,800246,157May 16 06:41 PM
Popovits Kimberly JPresident and CEOMay 14Sale38.0910,000380,877236,157May 16 06:41 PM
Shak StevenChief Scientific OfficerMay 09Option Exercise17.335,50095,315341,416May 11 03:10 PM
Shak StevenChief Scientific OfficerMay 09Sale36.645,500201,543335,916May 11 03:10 PM
Vaughn James JChief Commercial OfficerMay 02Sale32.501,49748,65329,655May 04 08:59 PM
Popovits Kimberly JPresident and CEOApr 16Option Exercise17.1815,000257,700251,157Apr 18 04:33 PM
Popovits Kimberly JPresident and CEOApr 16Sale33.1915,000497,880236,157Apr 18 04:33 PM
Popovits Kimberly JPresident and CEOMar 14Option Exercise17.185,00085,900241,157Mar 16 06:54 PM
Popovits Kimberly JPresident and CEOMar 14Sale32.015,000160,048236,157Mar 16 06:54 PM
Cole G BradleyCOOMar 13Option Exercise17.335,00086,65049,754Mar 15 04:31 PM
Cole G BradleyCOOMar 13Sale32.805,000164,01444,754Mar 15 04:31 PM
BAKER BROS. ADVISORS LPDirectorMar 09Option Exercise18.5049,500915,75011,369,282Mar 12 06:04 PM
Cole G BradleyCOOFeb 20Option Exercise17.335,00086,65049,754Feb 22 04:19 PM
Leber LauraChief Communication OfficerFeb 20Sale32.923,374111,08016,531Feb 22 04:24 PM
Febbo Phillip G.Chief Medical OfficerFeb 20Sale32.844,942162,29021,387Feb 22 04:19 PM
Cole G BradleyCOOFeb 20Sale32.895,000164,47444,754Feb 22 04:19 PM
Popovits Kimberly JPresident and CEOFeb 14Option Exercise17.1810,000171,80075,849Feb 15 04:02 PM
Popovits Kimberly JPresident and CEOFeb 14Sale32.9310,000329,33665,849Feb 15 04:02 PM
Popovits Kimberly JPresident and CEOJan 16Option Exercise17.1810,000171,80051,719Jan 18 09:30 PM
Popovits Kimberly JPresident and CEOJan 16Sale34.9910,000349,88541,919Jan 18 09:30 PM
Cole G BradleyCOOJan 09Option Exercise17.335,00086,65045,346Jan 10 09:17 PM
Cole G BradleyCOOJan 09Sale35.515,000177,56640,346Jan 10 09:17 PM
Vaughn James JChief Commercial OfficerJan 02Option Exercise17.332,16937,58930,481Jan 04 07:54 PM
Vaughn James JChief Commercial OfficerJan 02Sale34.093,004102,40627,477Jan 04 07:54 PM
Febbo Phillip G.Chief Medical OfficerDec 19Option Exercise27.005,000135,00023,134Dec 20 04:35 PM
Febbo Phillip G.Chief Medical OfficerDec 19Sale36.995,334197,29817,800Dec 20 04:35 PM
Leber LauraChief Communication OfficerDec 15Option Exercise17.339,000155,97024,754Dec 18 07:52 PM
Leber LauraChief Communication OfficerDec 15Sale35.009,000315,00015,754Dec 18 07:52 PM
Popovits Kimberly JPresident and CEODec 14Option Exercise17.2820,000345,53561,919Dec 18 07:51 PM
Leber LauraChief Communication OfficerDec 14Option Exercise21.5212,000258,24027,754Dec 18 07:52 PM
Leber LauraChief Communication OfficerDec 14Sale32.0012,000384,00015,754Dec 18 07:52 PM
Popovits Kimberly JPresident and CEODec 14Sale31.5020,000630,00041,919Dec 18 07:51 PM
Cole G BradleyCOODec 12Option Exercise17.335,00086,65044,935Dec 13 04:14 PM
Cole G BradleyCOODec 12Sale29.945,000149,70939,935Dec 13 04:14 PM